Explore Passage Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PASG.

Get the detailed quarterly/annual income statement for Passage Bio, Inc. (PASG). Find out the revenue, expenses and profit or loss over the last fiscal year.

For PASG, shares are up 24.26% over the past week while the Zacks Medical - Biomedical and Genetics industry is up 3.78% over the same time period.

Passage Bio (PASG) announced new interim results from the first six patients in its Phase 1/2 study for PBGM01 targeted at GM1 Gangliosidosis ((GM1)), Read full story here.

Passage Bio, Inc. (PASG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

Passage Bio (NASDAQ:PASG) traded higher on Thursday after the company announced a series of agreements with GEMMA Biotherapeutics, including a deal to out-license its programs targeting pediatric ...

The current price Passage Bio (PASG) is trading at is $0.32, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. People Also Watch ...